Veículo
WNCT-TV (EUA)
Em 2025: 0 notícias
Desde 1995: 4 notícias
Could intermittent fasting raise the risk of colon cancer?
Publicado em 26 agosto 2024
(NewsNation) — Intermittent fasting has been shown to have several health benefits, but new research shows it also may increase the risk of colon cancer.
In the study conducted on mice, Massachusetts Institute of Technology researchers looked at three groups: one that fasted for 24 hours and did not eat, another that fasted for 24 hours and ate whatever it wanted during a 24-hour “refeeding” period, and a third that ate whatever it wanted [...]
-
Your morning coffee may be more than a half million years old
Publicado em 15 abril 2024That coffee you slurped this morning? It’s 600,000 years old. Using genes from coffee plants around the world, researchers built a family tree for the world’s most popular type of coffee, known to scientists as Coffea arabica and to coffee lovers simply as “arabica.” The researchers, hoping to learn more about the plants to better protect them from pests and climate change, found that the species emerged around 600,000 years ago through natural crossbreeding of two [...]ver notícia -
Giant Magellan Telescope Expands Global Science Impact with Taiwanese Partner
Publicado em 20 fevereiro 2024PASADENA, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope today welcomes Academia Sinica Institute of Astronomy and Astrophysics (ASIAA), a distinguished Taiwanese research institute, into its international consortium. ASIAA's inclusion expands the consortium to 14 international research institutions, underscoring Giant Magellan's significance to the global astronomy community and the consortium's commitment to prioritizing global collaboration for the advancement [...]ver notícia -
Foresee Pharmaceuticals Announces Publication of Preclinical Data in the European Heart Journal Demonstrating the Therapeutic Potential of Foresee ALDH2 Activators in the Treatment of Heart Failure and Further Elucidating a Novel Mechanism of Action
Publicado em 08 novembro 2023TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today preclinical data in the European Heart Journal, demonstrating that activation of Aldehyde Dehydrogenase 2 (ALDH2) with Foresee's oral ALDH2 activator AD-9308, significantly ameliorates heart failure via the modulation of the Dicer-miRNA pathway in the heart. The article is cited "Kiyuna L, Candido D, Bechara L, Jesus I, Ramalho L, Krum B, et al. 4-hydroxynonenal impairs [...]ver notícia